99 related articles for article (PubMed ID: 31164609)
1. Avoiding the Interference of Doxorubicin with MTT Measurements on the MCF-7 Breast Cancer Cell Line.
Luis C; Castaño-Guerrero Y; Soares R; Sales G; Fernandes R
Methods Protoc; 2019 Apr; 2(2):. PubMed ID: 31164609
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity Studies of the Extracts, Fractions, and Isolated Compound of
Elufioye TO; Abdul AA; Moody JO
Pharmacognosy Res; 2017; 9(1):46-50. PubMed ID: 28250653
[TBL] [Abstract][Full Text] [Related]
3. Amphotericin B potentiates the anticancer activity of doxorubicin on the MCF-7 breast cancer cells.
Tavangar F; Sepehri H; Saghaeian Jazi M; Asadi J
J Chem Biol; 2017 Jul; 10(3):143-150. PubMed ID: 28685000
[TBL] [Abstract][Full Text] [Related]
4. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
[TBL] [Abstract][Full Text] [Related]
5. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant and Cytotoxic Effect of Barringtonia racemosa and Hibiscus sabdariffa Fruit Extracts in MCF-7 Human Breast Cancer Cell Line.
Amran N; Rani AN; Mahmud R; Yin KB
Pharmacognosy Res; 2016; 8(1):66-70. PubMed ID: 26941539
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy.
Gomes LR; Vessoni AT; Menck CF
Oncogene; 2015 Oct; 34(42):5329-40. PubMed ID: 25619836
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory and Cytotoxic Activities of Chrysin on Human Breast Adenocarcinoma Cells by Induction of Apoptosis.
Samarghandian S; Azimi-Nezhad M; Borji A; Hasanzadeh M; Jabbari F; Farkhondeh T; Samini M
Pharmacogn Mag; 2016 Jul; 12(Suppl 4):S436-S440. PubMed ID: 27761071
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies.
Peira E; Chirio D; Battaglia L; Barge A; Chegaev K; Gigliotti CL; Ferrara B; Dianzani C; Gallarate M
J Microencapsul; 2016 Jun; 33(4):381-90. PubMed ID: 27358106
[TBL] [Abstract][Full Text] [Related]
10. The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines.
Ilisso CP; Castellano M; Zappavigna S; Lombardi A; Vitale G; Dicitore A; Cacciapuoti G; Caraglia M; Porcelli M
Endocrine; 2015 Sep; 50(1):212-22. PubMed ID: 25577236
[TBL] [Abstract][Full Text] [Related]
11. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
Angelini A; Conti P; Ciofani G; Cuccurullo F; Di Ilio C
J Biol Regul Homeost Agents; 2013; 27(4):1029-37. PubMed ID: 24382184
[TBL] [Abstract][Full Text] [Related]
12. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
Angelini A; Ciofani G; Conti P
J Biol Regul Homeost Agents; 2015; 29(2):357-65. PubMed ID: 26122223
[TBL] [Abstract][Full Text] [Related]
13. Comparison of PrestoBlue and MTT assays of cellular viability in the assessment of anti-proliferative effects of plant extracts on human endothelial cells.
Boncler M; Różalski M; Krajewska U; Podsędek A; Watala C
J Pharmacol Toxicol Methods; 2014; 69(1):9-16. PubMed ID: 24103906
[TBL] [Abstract][Full Text] [Related]
14. [Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2].
Skaličková S; Löfelmann M; Gargulák M; Dočekalová M; Ruttkay-Nedecký B; Suchý P; Kepinská M; Kizek R
Klin Onkol; 2017; 30(Supplementum1):177-179. PubMed ID: 28471200
[TBL] [Abstract][Full Text] [Related]
15. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
16. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
18. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity of physodic acid and acetone extract from Hypogymnia physodes against breast cancer cell lines.
Studzińska-Sroka E; Piotrowska H; Kucińska M; Murias M; Bylka W
Pharm Biol; 2016 Nov; 54(11):2480-2485. PubMed ID: 27049956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
